Zurich, Switzerland

Frieder Mitzel

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Indena S.p.a.. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Frieder Mitzel. Retrieved from https://idiyas.com/inventor/frieder-mitzel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2012

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Frieder Mitzel: Innovator in Pharmaceutical Chemistry

Introduction

Frieder Mitzel is a notable inventor based in Zurich, Switzerland. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of processes for synthesizing important chemical compounds.

Latest Patents

Mitzel holds a patent for a process titled "Process for the preparation of (2R,3S)-3-phenylisoserine methyl ester acetate salt." This innovative process enables the enantioselective preparation of a useful building block for the synthesis of taxane derivatives. The method involves the resolution of racemic threo-phenylisoserine amide and its conversion into the desired compound.

Career Highlights

Mitzel is currently associated with Indena S.p.a., a company known for its expertise in the development of plant-based active ingredients for the pharmaceutical and nutraceutical industries. His work has contributed to advancements in the synthesis of complex molecules that are vital for drug development.

Collaborations

Mitzel has collaborated with esteemed colleagues such as Daniele Ciceri and Bruno Gabetta. Their combined expertise has fostered innovation and progress in their respective fields.

Conclusion

Frieder Mitzel's contributions to pharmaceutical chemistry through his innovative patent and collaboration with industry professionals highlight his role as a key inventor in the field. His work continues to influence the development of important pharmaceutical compounds.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…